Standard dosing algorithms could be responsible for the higher rates of thyrotoxicosis among older women vs men prescribed levoythroxine.

Topline data were announced from a phase 3 trial evaluating orforglipron in adults with T2D and inadequate glycemic control with diet and exercise alone.

The FDA is shifting away from animal testing in the development of monoclonal antibody therapies and other drugs.

Are there disparities in obesity prevalence and comorbidities based on sex and gender, and how should it inform treatment?

Older adults who have experienced parental divorce in childhood may have a higher likelihood of developing stroke.

Multiple live births were more prevalent among lesbian patients than heterosexual patients in medically assisted reproduction.

Patients that use noncigarette tobacco products may have elevated subclinical markers related to inflammation, thrombosis, and atherosclerosis.

The FDA has approved Isturisa (osilodrostat) for the treatment of endogenous hypercortisolemia in adults with Cushing syndrome for whom surgery is not an option or has not been curative.

The FDA has cleared the Dexcom G7 15 Day continuous glucose monitoring system for individuals 18 years and older with ...

Patients with T1D experienced greater reductions in risk for cardiovascular disease with empagliflozin compared with placebo.

Pfizer has made the decision to discontinue the clinical development program for danuglipron, an oral GLP-1 receptor agonist, being investigated for chronic weight management.

Patients with diabetes may not need to have a HbA1c value lower than 8% before cataract surgery to reduce the risk for endophthalmitis.